Does Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) warrant a purchase right now? What to Consider Before Making a Decision
Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) shares traded -2.09% lower at $83.72 on Wall Street last session. In accordance with the data, 29 analysts cover Biomarin Pharmaceutical Inc. (NASDAQ:BMRN). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $170.00 and a low of $78.00, […]
The shares of BioMarin Pharmaceutical Inc. (BMRN) have recorded the market capitalization of 16.31B
The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) last traded at $87.93, up 0.37% from the previous session. Data from the available sources indicates that BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is covered by 26 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
Can BioMarin Pharmaceutical Inc. (BMRN) stock recover despite sales dropping?
In yesterday’s Wall Street session, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares traded at $85.00, down -1.94% from the previous session. 26 analysts cover BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $200.00 and a […]